ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

TMCI Treace Medical Concepts Inc

11,00
0,29 (2,71%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Treace Medical Concepts Inc TMCI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,29 2,71% 11,00 23:18:23
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
11,00 10,82 11,24 11,00 10,71
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202413:00GLOBETreace Medical Named First Medical Device Partner and..
17.4.202413:00GLOBETreace to Present at Bank of America Health Care Conference
16.4.202413:00GLOBETreace Announces First Annual National Bunion Day
09.4.202413:00GLOBETreace to Report First Quarter 2024 Financial Results
25.3.202412:00GLOBETreace Celebrates 100,000 Lapiplasty® 3D Bunion Correction®..
27.2.202422:13EDGAR2Form 8-K - Current report
27.2.202422:05GLOBETreace Medical Concepts Reports Fourth Quarter and Full-Year..
09.2.202423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202422:05GLOBETreace to Report Fourth Quarter and Full-Year 2023 Financial..
02.2.202418:00GLOBETreace Announces Interim 3-Year ALIGN3D™ Clinical Study Data..
01.2.202413:00GLOBETreace to Highlight Latest Product Innovations and ALIGN3D™..
13.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.1.202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:16EDGAR2Form 8-K - Current report
08.1.202413:00GLOBETreace Announces Preliminary, Unaudited Fourth Quarter and..
19.12.202313:00GLOBETreace to Present at 42nd Annual J.P. Morgan Healthcare..
09.11.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202322:07EDGAR2Form 8-K - Current report
09.11.202322:05GLOBETreace Medical Concepts Reports Third Quarter 2023 Financial..
04.11.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.11.202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202312:00GLOBETreace to Present at Stifel 2023 Healthcare Conference
16.10.202313:00GLOBETreace to Report Third Quarter 2023 Financial Results
06.10.202303:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.9.202313:00GLOBETreace Highlights New Product Innovations and Updated..
14.9.202322:05GLOBETreace Medical Concepts Announces New Patent Covering..
11.9.202322:05GLOBETreace Medical Concepts Announces Limited Market Release of..
22.8.202322:05GLOBETreace Announces Participation in the 21st Annual Morgan..
21.8.202313:00GLOBETreace Medical Concepts Appoints Nathan Minnich as Senior..
09.8.202314:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:08EDGAR2Form 8-K - Current report
08.8.202322:05GLOBETreace Medical Concepts Reports Second Quarter 2023..
24.7.202322:05GLOBETreace Announces Participation in the UBS Medtech, Tools and..
18.7.202322:15GLOBETreace to Report Second Quarter 2023 Financial Results on..
12.7.202322:15GLOBETreace Appoints Julie Dewey as Chief Communications and..
13.6.202322:15GLOBETreace Medical Completes Acquisition of Technology Enabling..
01.6.202322:15GLOBETreace Medical Concepts to Acquire Technology Enabling..
08.5.202322:05GLOBETreace Medical Concepts Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock